Back

Growth differentiation factor 15 and all-cause and cause-specific mortality in patients with suspected or known coronary artery disease: The ANOX and EXCEED-J Studies

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Hiromichi Wada

NHO Kyoto Medical Centre, Kyoto (Japan)

8 More presentations in this session

Presentation thumbnail
Discussant - Biomarkers and assessing outcomes in coronary artery disease
Presentation thumbnail
Association between cortisol, glucose and hospital mortality in acute coronary syndromes: a causal inference analysis.
Doctor S. Swieszkowski (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality
Doctor S. Fathieh (London, GB)
Abstract Slides Video
Presentation thumbnail
Comparative predictive value of troponin I and troponin T for in-hospital ischemic and bleeding events in acute coronary syndrome
Doctor J. Costabel (Buenos Aires, AR)
Abstract
Presentation thumbnail
Lipoprotein(a) levels above 70 mg/dL are an independent predictor for long-term major adverse cardiovascular events in patients with premature (<40 years) acute coronary syndrome
Professor L. Rallidis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Growth differentiation factor-15 and 5-years cardiovascular risk in chest pain patients presenting to the emergency department: a multicenter cohort study
thumbnail
Congress Presentation
Growth differentiation factor-15 is associated with myocardial infarction and death at 30 and 90 days in ED patients with suspected acute coronary syndrome
thumbnail
Congress Presentation
Plasma levels of human growth differentiation factor 15 (GDF-15) and their effect of alirocumab on major adverse cardiovascular events and all-cause death after acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources